Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis

Purpose of reviewTo summarize recent developments using non-conventional MRI techniques to measure neuroprotection, repair and plasticity in multiple sclerosis. Recent findingsRecent advances in our understanding of the pathogenesis of multiple sclerosis, particularly as it relates to the development of chronic disability, have led away from a ‘lesion-centric’ view of multiple sclerosis towards investigating neurodegeneration and pathology in normal appearing brain tissue. Advanced image processing techniques that measure atrophy globally and regionally also have provided insight into the putative mechanisms that contribute to neurodegeneration. In addition, novel quantitative imaging techniques that are more specific than conventional MRI for myelin and axonal pathology have been instrumental in revealing the dynamic nature of injury and repair of myelin and axons in lesions. Novel imaging techniques that are sensitive to the pathology of myelin and axons that happens in multiple sclerosis also provide a method by which we can measure neuroprotection and test the efficacy of putative therapeutic agents in multiple sclerosis. SummaryNon-conventional MRI techniques have contributed to a greater understanding of the complex pathogenesis of neurodegenerative phenomena that occur in multiple sclerosis. The pathological specificity of these novel imaging methods enables the evaluation of the neuroprotective effects of novel therapeutic strategies.

[1]  Elizabeth Fisher,et al.  Imaging correlates of axonal swelling in chronic multiple sclerosis brains , 2007, Annals of neurology.

[2]  Hompson,et al.  A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .

[3]  Marco Battaglini,et al.  Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.

[4]  D. Louis Collins,et al.  Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion , 2007, NeuroImage.

[5]  Nick C Fox,et al.  Magnetic resonance imaging measures of brain atrophy in multiple sclerosis , 2006, Journal of magnetic resonance imaging : JMRI.

[6]  W. Klunk,et al.  Imaging of CNS myelin by positron-emission tomography. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P M Matthews,et al.  Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. , 2000, Brain : a journal of neurology.

[8]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[9]  Stephen G Waxman,et al.  Na+ channel expression along axons in multiple sclerosis and its models. , 2004, Trends in pharmacological sciences.

[10]  Gareth J. Barker,et al.  Diffusion tensor imaging of post mortem multiple sclerosis brain , 2007, NeuroImage.

[11]  P. Matthews,et al.  Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.

[12]  G. Buzsáki,et al.  Inhibition and Brain Work , 2007, Neuron.

[13]  Bruce D. Trapp,et al.  Pathogenesis of axonal and neuronal damage in multiple sclerosis , 2007, Neurology.

[14]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[15]  D. Arnold,et al.  The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis , 2007, Multiple sclerosis.

[16]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[17]  Susumu Mori,et al.  High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. , 2007, Brain : a journal of neurology.

[18]  P. V. van Zijl,et al.  Three‐dimensional tracking of axonal projections in the brain by magnetic resonance imaging , 1999, Annals of neurology.

[19]  H. McFarland,et al.  Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis , 2006, Neurology.

[20]  R I Grossman,et al.  Magnetization transfer in multiple sclerosis , 1994, Annals of neurology.

[21]  Daniel Pelletier,et al.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.

[22]  A. MacKay,et al.  In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.

[23]  Stephen Smith,et al.  Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. , 2003, Brain : a journal of neurology.

[24]  Nick C. Fox,et al.  The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.

[25]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[26]  J L Ostuni,et al.  Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis , 2001, Multiple sclerosis.

[27]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[28]  J H Simon,et al.  Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.

[29]  P M Matthews,et al.  Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.

[30]  P M Matthews,et al.  Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. , 2002, Brain : a journal of neurology.

[31]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[32]  H. Lassmann Multiple sclerosis: Is there neurodegeneration independent from inflammation? , 2007, Journal of the Neurological Sciences.

[33]  F. Condé,et al.  Early N-Acetylaspartate Depletion Is a Marker of Neuronal Dysfunction in Rats and Primates Chronically Treated with the Mitochondrial Toxin 3-Nitropropionic Acid , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  P M Matthews,et al.  Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.

[35]  My-Van Au Duong,et al.  Functional magnetic resonance imaging and cognition at the very early stage of MS , 2006, Journal of the Neurological Sciences.

[36]  P M Matthews,et al.  Non-invasive mapping of brain functions and brain recovery: applying lessons from cognitive neuroscience to neurorehabilitation. , 2004, Restorative neurology and neuroscience.

[37]  P. Narayana,et al.  Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging , 2007, American Journal of Neuroradiology.

[38]  C. Laule,et al.  Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology , 2006, Multiple sclerosis.

[39]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[40]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[41]  R I Grossman,et al.  Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden , 1996, Magnetic resonance in medicine.

[42]  H. Schild,et al.  Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy , 2007, American Journal of Neuroradiology.

[43]  E. Radue,et al.  Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a , 2005, Neurology.

[44]  P M Matthews,et al.  The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis , 2000, Annals of neurology.

[45]  Frederik Barkhof,et al.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. , 2007, Archives of neurology.

[46]  R. Henkelman,et al.  Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.

[47]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[48]  David H. Miller,et al.  Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain , 2007, Journal of magnetic resonance imaging : JMRI.

[49]  Dieter Vaitl,et al.  Distinct mechanisms of altered brain activation in patients with multiple sclerosis , 2007, NeuroImage.

[50]  Nick C Fox,et al.  Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[51]  Nick C. Fox,et al.  Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX , 2007, NeuroImage.

[52]  V. M. Anderson BSc,et al.  Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: Sample size estimates , 2007, Journal of Neurology.

[53]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[54]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.